The burgeoning medical field poses all new challenges for the plastics industry - and TriStar leads the way in manufacturing plastic components for enhanced patient outcomes.
Our clients supply the leaders in the medical, biotechnology, and pharmaceutical industries, and we’ve helped them realize the cost and yield benefits of altering plastic material for a variety of scientific applications.
Did you know?
TriStar was the first to use surface modification to alter PEEK and PVC materials to accept timed-release medications used in surgery and recovery? And that our engineers have improved the molecular adhesion of microplates and microfludic devices used in cell generation?
We’ve also applied our surface modification techniques to the following devices:
Pharmaceutical
- Drug delivery and storage
Biotechnology
- Micro-arrays, micro-fluidics, MEMs
Optical
- Polycarbonate, glass, CR39, TrivexTM, PMMA, and urethane for lenses, films, depositions, and MOEMs
Want to learn more? Consult our experts to help you identify the best modification process for your unique medical challenge. We’ll choose from plasma, corona, photolysis, and parylene techniques, and help you evaluate the unique benefits of each treatment.
We also offer you:
- Contract review
- Analytical assistance
- Surface modification equipment
